Cargando…
Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academic Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849495/ http://dx.doi.org/10.1016/j.ymgme.2020.12.201 |
| _version_ | 1783645314581790720 |
|---|---|
| author | Peris, Jorge Esteban, María José Robert, Jaqueline Wikman, Philip Seguí, José Miguel Cañizares, Ruth Esteve, Pedro Chazarra, Paloma Asensio, María Luisa Martínez, Verónica Sempere, Azucena Balaz, David Riaño, Andrea Lajara, Lourdes Giner, Vicente |
| author_facet | Peris, Jorge Esteban, María José Robert, Jaqueline Wikman, Philip Seguí, José Miguel Cañizares, Ruth Esteve, Pedro Chazarra, Paloma Asensio, María Luisa Martínez, Verónica Sempere, Azucena Balaz, David Riaño, Andrea Lajara, Lourdes Giner, Vicente |
| author_sort | Peris, Jorge |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7849495 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Academic Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78494952021-02-02 Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases Peris, Jorge Esteban, María José Robert, Jaqueline Wikman, Philip Seguí, José Miguel Cañizares, Ruth Esteve, Pedro Chazarra, Paloma Asensio, María Luisa Martínez, Verónica Sempere, Azucena Balaz, David Riaño, Andrea Lajara, Lourdes Giner, Vicente Mol Genet Metab Article Academic Press 2021-02 2021-02-01 /pmc/articles/PMC7849495/ http://dx.doi.org/10.1016/j.ymgme.2020.12.201 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Peris, Jorge Esteban, María José Robert, Jaqueline Wikman, Philip Seguí, José Miguel Cañizares, Ruth Esteve, Pedro Chazarra, Paloma Asensio, María Luisa Martínez, Verónica Sempere, Azucena Balaz, David Riaño, Andrea Lajara, Lourdes Giner, Vicente Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| title | Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| title_full | Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| title_fullStr | Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| title_full_unstemmed | Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| title_short | Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| title_sort | impact of sars-cov-2 pandemic on the first spanish national domiciliary enzymatic infusion strategy for lysosomal diseases |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849495/ http://dx.doi.org/10.1016/j.ymgme.2020.12.201 |
| work_keys_str_mv | AT perisjorge impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT estebanmariajose impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT robertjaqueline impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT wikmanphilip impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT seguijosemiguel impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT canizaresruth impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT estevepedro impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT chazarrapaloma impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT asensiomarialuisa impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT martinezveronica impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT sempereazucena impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT balazdavid impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT rianoandrea impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT lajaralourdes impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases AT ginervicente impactofsarscov2pandemiconthefirstspanishnationaldomiciliaryenzymaticinfusionstrategyforlysosomaldiseases |